Stankovikj, Svetlana
Full Name
Stankovikj, Svetlana
Main Affiliation
Email
svetlana.stankovikj@medf.ukim.edu.mk
Loading...
2
0
5
0
false
Loading...
3
0
5
0
false
Date issued
Type
Fulltext
Results 1-19 of 19 (Search time: 0.02 seconds).
Preview | Title | Author(s) | Issue Date | Type | |
---|---|---|---|---|---|
1 | Acute complications in multiple myeloma | Stankovikj, Svetlana ; Martinova, Kata | 2017 | Article | |
2 | Analysis from Final data from Multinational, Non-Interventional, Observational Emmos Study (NCTO1241396) in Patients with Multiple Myeloma (MM) in Real-World Clinical Practice | M. Mohty; E. Terpos; M-V. Mateos; A. Palumbo; S. Lejniece; M. Beksac; M.A. Bekadja; W. Legiec; M. Dimopoulos; Svetlana Stankovic ; M.S. Duran; V. De Stefano; A. Corso; Y. Kochkareva; E. Laane; C. Berthou; H-J. Salwender; Z. Masliak; V. Peceliunas; W. Willenbacher; J. Da Salva; V. Louw; D. Nemet; Z. Borbenyl; U. Abadi; R.S.Pe ersen; P. Cernelc; A. Potamianou; C. Couturier; R. Olie; C. Feys; F. Thoret-Bauchert; M. Boccadoro | 2015 | Proceeding article | |
3 | Autologous stem-cell transplantation in patients with multiple myeloma | Z. Stojanoski ; B. Georgievski ; L. Cevreska; A. Stojanovic; A. Pivkova ; S. Genadieva Stavric ; S. Stankovic ; A. Stojanovska Karadzova | 2008 | Article | |
4 | Bondronat in the treatment of bone lesions in multiple myeloma | S. Stankovic ; L. Cevreska; O. Karanfilski ; N. Siljanovski; T. Smilevska; Z. Stojanoski ; L. Hadzi-Pecova; M. Lozance; A. Ljatifi; A. Stojanovic | 2006 | Proceeding article | |
5 | Bondronat is essential accesory treatment in multiple myeloma with negligible side effects | Svetlana Stankovic ; Lidija Cevreska; Tatjana Smilevska; Aleksandar Stojanovic; Oliver Karanfilski ; Borce Georgievski ; Arif Ljatifi | 2006 | Proceeding article | |
6 | Erythropoetin in the treatment of multiple myeloma related anemia | S. Stankovic ; T. Smilevska; S. Genadieva Stavric ; M. Lozance; S. Trajkova ; G. Kostova; L. Hadzi-Pecova; A. Stojanovic | 2004 | Proceeding article | |
7 | Frontline induction therapy for multiple myeloma (MM) in real-world clinical practice: Third interim analysis of the multinational, observational EMMOS study (NCT01241396) | Mohamed Mohty; Evangelos Terpos; Maria-Victoria Mateos; Antonio Palumbo; Wojciech Legiec; Meral Beksac; Edward Laane; Mohamed Amine Bekadja; Damir Nemet; Valdas Peceliunas; Michele Cavo; Philipe Moreau; Tomas Masszi; Peter Cernelc; Jaime Perez de Oteyza; Hans Salwender; Uri Abadi; Meletios Dimopoulos; Svetlana Stankovic ; GalinaNikolaevna Salogub; Wolfgang Willenbacher; Niels Abildgaard; Karen Gunther; Joao Silva; Sandra Lejniece; Irina Dyagil; Anna Potamianon; Catherine Couturier; Robert Olie; Caroline Feys; Florence Thort-Bander; Mario Boccadoro | 2015 | Proceeding article | |
8 | Frontline therapy for multiple myeloma in real-world clinical practice: Results from the third interim analysis of the multinational, non-interventional, observational EMMOS study | Mohamed Mohty; Evangelos Terpos; Maria-Victoria Mateos; Antonio Palumbo; Sandra Lejniece; Meral Beksac; Mohamed Amine Bekadja; Wojciech Legiec; Meletios Dimopoulos; Svetlana Stankovic ; Maria Soledad Duran; Valerio De Stefano; Yulia Kochareva; Edward Laane; Christian Berthou; Hans Salwender; Zvenislava Masliak; Valdas Peceliunas; Wolfgang Willenbacher; Joao Silva; Vernon Louw; Damir Nemet; Zita Borbenyl; Uri Abadi; Robert Schou Pedersen; Peter Cernelc; Anna Potamianon; Catherine Couturier; Robert Olie; Caroline Feys; Florence Thort-Bander; Mario Boccadoro | 2015 | Proceeding article | |
9 | Multiple myeloma related anemia treated with erythropetin | Svetlana Stankovic ; Aleksandar Stojanovic; Nikola Siljanovski; Zlate Stojanoski ; Liljana Hadzi-Pecova; Sanja Trajkova ; Marija Lozance | 2005 | Proceeding article | |
10 | Multiple myeloma treatment in real-world clinical practice: a focus on induction regimens prior to autologous stem cell transplantation from the prospective, multinational, non-interventional EMMOS study | Mohamed Mohty; Evangelos Terpos; Maria-Victoria Mateos; Michele Cavo; Sandra Lejniece; Meral Beksac; Wojciech Legiec; Mohamed Amin Bekadja; Meletios Dimopoulos; Svetlana Stankovic ; Maria Soledad Duran; Valerio Dr Stefano; Alessandro Corso; Yulia Kochkareva; Edward Laane; Christian Berthou; Hans Salwender; Zvenislava Masliak; Valdas Peceliunas; Wolfgang Willenbacher; Joao Silva; Vernon Louw; Damir Nemet; Zita Borbenyl; Uri Abadi; Robert Schou Pedersen; Peter Cernalc; Anna Potamianou; Catherine Couturier; Caroline Feys; Florence Thoret-Bauchet; Mario Boccadoro | 3-Mar-2019 | Proceeding article | |
11 | Multiple myeloma treatment in real-world clinical practice: results of a prospective, multinational, non-interventional study | Mohamed Mohty; Evangelos Terpos; Maria-Victoria Mateos; Michele Cavo; Sandra Lejniece; Meral Beksac; Mohamed Amine Bekadja; Wojciech Legiec; Meletios Dimopoulos; Svetlana Stankovic ; Maria Soledad Duran; Valerio De Stefano; Alessandro Corso; Yulia Kochareva; Edward Laane; Christian Berthou; Hans Salwender; Zvenislava Masliak; Valdas PeceliunasWolfrang Wielenbacher; Joao Silva; Vernon Louw; Damir Nemet; Zita Borbenyi; Uri Abadi; Robert Schou Pedersen; Peter Cernelc; Anna Potamianon; Caroline Feys; Florence Thort-Bander; Mario Boccadoro | Oct-2018 | Article | |
12 | Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates | M. Pavkovic ; G. Petrushevska ; T. Sotirova ; S. Trpkovska-Terzieva; O. Karanfilski ; L. Cevreska ; S. Stankovic ; A. Stojanovic | 2010 | Proceeding article | |
13 | Our initial experience with Bortezomib in the treatment of refractory myeloma | Svetlana Stankovic ; Lidija Cevreska; Aleksandar Stojanovic; Tatjana Smilevska; Borce Georgievski ; Oliver Karanfilski | 2006 | Proceeding article | |
14 | Outcome of first salvage therapy for multiple myeloma (MM) in real-world clinical practice: Results from the third interim analysis of the multinational, observational, non-interventional EMMOS study | M. Mohty; E. Terpos; M.-V. Mateos; A. Palumbo; W. Legiec; M. Beksac; E. Laane; M.A. Bekadja; D. Nemet; V. Peelinas; M. Cavo; P. Moreau; T. Masszi; P. Ernel; J. Perez de Oteyza; H. Salwender; U. Abadi; M. Dimipoulos; S. Stankovic ; G.N. Salogub; W. Willenbacher; N. Abilgaard; K. Gunther; J. Silva; S. Lejniece; I. Dyagil; A. Potaminanou; C. Couturier; R. Olie; C. Feys; F. Thoret-Bauchet; M. Boccadoro | 2015 | Proceeding article | |
15 | Outcome of treatment for first versus later relapse in multiple myeloma (MM) in real-world clinical practice: Results from the third interin analysis of the multinational, non-interventional, observational EMMOS study | M. Mohthy; E. Terpos; M.V. Mateos; A. Palumbo; S. Lejniece; M. Beksac; M.A. Bekadja; W. Legiec; M. Dimopoulos; S. Stankovic ; M.S. Durán; V. De Stefano; Y. Kochkareva; E. Laane; C. Berthou; H. Salwender; Z. Masliak; V. Pe eli nas; W. Willenbacher; J. Silva; V. Louw; D. Nemet; Z. Borbényi; U. Abadi; R.S. Pedersen; P. Ernel; A. Potamianou; C. Couturier; R. Olie; C. Feys; F. Thoret-Bauchet; M. Boccadoro | 2015 | Proceeding article | |
16 | Patients with multiple myeloma and prolonged survival after conventional chemotherapy | S. Stankovic ; N. Siljanovski; T. Smilevska; L. Hadzi-Pecova; S. Genadieva Stavric ; M. Pavkovic ; L. Cevreska | 2003 | Proceeding article | |
17 | Prognostic factors in multiple myeloma | S. G. Stankovic ; A. Stojanovic; L. Cevreska ; T. Smilevska; O. Karanfilski ; B. Georgievski ; N. Siljanovski; L. Hadzi-Pecova ; M. Pavkovic ; S. Stavric-Genadieva ; M. Lozance | 2002 | Proceeding article | |
18 | Severe acute renal failure as a result of TLS after Bortezomib therapy in a case of therapy-resistant multiple myeloma | S. Stankovic | 2007 | Proceeding article | |
19 | Survival probabilities in patients with multiple myeloma treated at the Clinic of hematology in Skopje | S.Stankovic | 2009 | Proceeding article |